nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—Sulfonamides—Acetazolamide—epilepsy syndrome	0.447	0.569	CiPCiCtD
Sulfisoxazole—Sulfonamides—Zonisamide—epilepsy syndrome	0.339	0.431	CiPCiCtD
Sulfisoxazole—CYP2C9—Trimethadione—epilepsy syndrome	0.0285	0.17	CbGbCtD
Sulfisoxazole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0268	0.16	CbGbCtD
Sulfisoxazole—CYP2C9—Carbamazepine—epilepsy syndrome	0.0193	0.115	CbGbCtD
Sulfisoxazole—CYP2C9—Primidone—epilepsy syndrome	0.018	0.107	CbGbCtD
Sulfisoxazole—CYP2C9—Phenytoin—epilepsy syndrome	0.0173	0.103	CbGbCtD
Sulfisoxazole—CYP2C9—Propofol—epilepsy syndrome	0.0161	0.0962	CbGbCtD
Sulfisoxazole—CYP2C9—Phenobarbital—epilepsy syndrome	0.0154	0.0919	CbGbCtD
Sulfisoxazole—CYP2C9—Diazepam—epilepsy syndrome	0.0146	0.0872	CbGbCtD
Sulfisoxazole—CYP2C9—Valproic Acid—epilepsy syndrome	0.0115	0.0687	CbGbCtD
Sulfisoxazole—Sulfamethazine—ALB—epilepsy syndrome	0.000116	0.167	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—epilepsy syndrome	0.000113	0.164	CrCbGaD
Sulfisoxazole—Sulfamethizole—ALB—epilepsy syndrome	8.76e-05	0.127	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2C19—epilepsy syndrome	7.77e-05	0.113	CrCbGaD
Sulfisoxazole—Sulfaphenazole—CYP2D6—epilepsy syndrome	7.76e-05	0.112	CrCbGaD
Sulfisoxazole—Dapsone—CYP2C19—epilepsy syndrome	6.93e-05	0.1	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2D6—epilepsy syndrome	5.76e-05	0.0834	CrCbGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CHRM3—epilepsy syndrome	4.94e-05	0.00107	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—epilepsy syndrome	4.92e-05	0.0712	CrCbGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDYN—epilepsy syndrome	4.82e-05	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM1—epilepsy syndrome	4.82e-05	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR7—epilepsy syndrome	4.82e-05	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CHRM1—epilepsy syndrome	4.82e-05	0.00105	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	4.76e-05	0.00104	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—BDKRB1—epilepsy syndrome	4.64e-05	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CHRM2—epilepsy syndrome	4.64e-05	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SSTR4—epilepsy syndrome	4.61e-05	0.001	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SSTR5—epilepsy syndrome	4.61e-05	0.001	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AVP—epilepsy syndrome	4.59e-05	0.000999	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GAL—epilepsy syndrome	4.54e-05	0.000987	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GABBR1—epilepsy syndrome	4.52e-05	0.000983	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CHRM3—epilepsy syndrome	4.48e-05	0.000976	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM5—epilepsy syndrome	4.48e-05	0.000976	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR10—epilepsy syndrome	4.42e-05	0.000963	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HRH3—epilepsy syndrome	4.33e-05	0.000943	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—epilepsy syndrome	4.32e-05	0.0625	CrCbGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.3e-05	0.000936	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OPRM1—epilepsy syndrome	4.26e-05	0.000928	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CHRM2—epilepsy syndrome	4.22e-05	0.000918	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CX3CL1—epilepsy syndrome	4.22e-05	0.000918	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—BDKRB1—epilepsy syndrome	4.22e-05	0.000918	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GABBR1—epilepsy syndrome	4.1e-05	0.000893	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR3—epilepsy syndrome	4.03e-05	0.000876	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.01e-05	0.000872	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRH3—epilepsy syndrome	3.93e-05	0.000856	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPY—epilepsy syndrome	3.92e-05	0.000854	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	3.92e-05	0.000853	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR5—epilepsy syndrome	3.9e-05	0.00085	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OPRM1—epilepsy syndrome	3.87e-05	0.000843	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM2—epilepsy syndrome	3.87e-05	0.000841	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR2A—epilepsy syndrome	3.82e-05	0.000831	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL2—epilepsy syndrome	3.79e-05	0.000824	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CRH—epilepsy syndrome	3.79e-05	0.000824	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OXT—epilepsy syndrome	3.79e-05	0.000824	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	3.69e-05	0.000802	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	3.69e-05	0.000802	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR3—epilepsy syndrome	3.66e-05	0.000796	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AGT—epilepsy syndrome	3.62e-05	0.000789	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPY—epilepsy syndrome	3.56e-05	0.000775	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SSTR3—epilepsy syndrome	3.5e-05	0.000761	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL2—epilepsy syndrome	3.44e-05	0.000748	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OXT—epilepsy syndrome	3.44e-05	0.000748	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CRH—epilepsy syndrome	3.44e-05	0.000748	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL3—epilepsy syndrome	3.44e-05	0.000748	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—SST—epilepsy syndrome	3.42e-05	0.000745	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR2—epilepsy syndrome	3.42e-05	0.000745	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.42e-05	0.000745	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.35e-05	0.000729	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPY2R—epilepsy syndrome	3.35e-05	0.000729	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR8—epilepsy syndrome	3.35e-05	0.000729	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SSTR1—epilepsy syndrome	3.35e-05	0.000729	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR9—epilepsy syndrome	3.35e-05	0.000729	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.35e-05	0.000729	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM3—epilepsy syndrome	3.29e-05	0.000715	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM4—epilepsy syndrome	3.29e-05	0.000715	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.23e-05	0.000703	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SSTR2—epilepsy syndrome	3.23e-05	0.000702	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DUSP4—epilepsy syndrome	3.23e-05	0.000702	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.22e-05	0.0007	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.22e-05	0.0007	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	3.17e-05	0.000689	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CNR1—epilepsy syndrome	3.16e-05	0.000688	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.15e-05	0.000685	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	3.15e-05	0.000685	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.12e-05	0.00068	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM8—epilepsy syndrome	3.12e-05	0.000678	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PGF—epilepsy syndrome	3.12e-05	0.000678	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR2—epilepsy syndrome	3.11e-05	0.000677	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—SST—epilepsy syndrome	3.11e-05	0.000677	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.1e-05	0.000676	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR7—epilepsy syndrome	3.08e-05	0.000671	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—POMC—epilepsy syndrome	3.05e-05	0.000664	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.04e-05	0.000662	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL2—epilepsy syndrome	2.98e-05	0.00065	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.98e-05	0.000649	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNAO1—epilepsy syndrome	2.97e-05	0.000647	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OPRD1—epilepsy syndrome	2.97e-05	0.000647	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT3—epilepsy syndrome	2.94e-05	0.000639	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.92e-05	0.000636	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL12—epilepsy syndrome	2.92e-05	0.000636	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CNR1—epilepsy syndrome	2.87e-05	0.000624	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLCB1—epilepsy syndrome	2.86e-05	0.000622	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM1—epilepsy syndrome	2.85e-05	0.00062	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR7—epilepsy syndrome	2.85e-05	0.00062	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CHRM1—epilepsy syndrome	2.85e-05	0.00062	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDYN—epilepsy syndrome	2.85e-05	0.00062	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	2.84e-05	0.000618	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.8e-05	0.00061	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR7—epilepsy syndrome	2.8e-05	0.000609	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.79e-05	0.000608	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HBEGF—epilepsy syndrome	2.72e-05	0.000591	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CDC42—epilepsy syndrome	2.68e-05	0.000583	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GAL—epilepsy syndrome	2.68e-05	0.000583	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GFAP—epilepsy syndrome	2.68e-05	0.000583	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT3—epilepsy syndrome	2.67e-05	0.00058	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP2—epilepsy syndrome	2.65e-05	0.000577	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CHRM3—epilepsy syndrome	2.65e-05	0.000577	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM5—epilepsy syndrome	2.65e-05	0.000577	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.62e-05	0.00057	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AVP—epilepsy syndrome	2.59e-05	0.000565	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.55e-05	0.000556	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CX3CR1—epilepsy syndrome	2.54e-05	0.000553	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CX3CL1—epilepsy syndrome	2.49e-05	0.000542	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CHRM2—epilepsy syndrome	2.49e-05	0.000542	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BDKRB1—epilepsy syndrome	2.49e-05	0.000542	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.46e-05	0.000535	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CDC42—epilepsy syndrome	2.43e-05	0.00053	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GABBR1—epilepsy syndrome	2.42e-05	0.000527	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AVP—epilepsy syndrome	2.36e-05	0.000513	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRH3—epilepsy syndrome	2.32e-05	0.000506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OPRM1—epilepsy syndrome	2.29e-05	0.000498	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.23e-05	0.000486	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR5—epilepsy syndrome	2.21e-05	0.00048	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA13—epilepsy syndrome	2.17e-05	0.000471	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR3—epilepsy syndrome	2.16e-05	0.00047	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.16e-05	0.00047	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPY—epilepsy syndrome	2.1e-05	0.000458	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ATP2A2—epilepsy syndrome	2.1e-05	0.000458	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGT—epilepsy syndrome	2.05e-05	0.000446	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OXT—epilepsy syndrome	2.03e-05	0.000442	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HSPB1—epilepsy syndrome	2.03e-05	0.000442	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL2—epilepsy syndrome	2.03e-05	0.000442	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL3—epilepsy syndrome	2.03e-05	0.000442	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CRH—epilepsy syndrome	2.03e-05	0.000442	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR5—epilepsy syndrome	2e-05	0.000436	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2A—epilepsy syndrome	1.96e-05	0.000427	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.89e-05	0.000412	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TSC1—epilepsy syndrome	1.89e-05	0.000411	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTK2B—epilepsy syndrome	1.89e-05	0.000411	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGT—epilepsy syndrome	1.86e-05	0.000405	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR2—epilepsy syndrome	1.84e-05	0.0004	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK2—epilepsy syndrome	1.84e-05	0.0004	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SST—epilepsy syndrome	1.84e-05	0.0004	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DUSP6—epilepsy syndrome	1.82e-05	0.000396	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRA2A—epilepsy syndrome	1.8e-05	0.000391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLAT—epilepsy syndrome	1.79e-05	0.000389	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.74e-05	0.000379	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BDKRB2—epilepsy syndrome	1.73e-05	0.000376	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL12—epilepsy syndrome	1.73e-05	0.000376	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—POMC—epilepsy syndrome	1.72e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCB—epilepsy syndrome	1.72e-05	0.000374	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6ST—epilepsy syndrome	1.71e-05	0.000373	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUNB—epilepsy syndrome	1.69e-05	0.000369	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CNR1—epilepsy syndrome	1.69e-05	0.000369	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLCB1—epilepsy syndrome	1.69e-05	0.000368	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR7—epilepsy syndrome	1.65e-05	0.00036	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.64e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.64e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.64e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.64e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.64e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.64e-05	0.000357	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HBEGF—epilepsy syndrome	1.61e-05	0.000349	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT3—epilepsy syndrome	1.58e-05	0.000343	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—POMC—epilepsy syndrome	1.57e-05	0.000341	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADAM10—epilepsy syndrome	1.54e-05	0.000335	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL2—epilepsy syndrome	1.53e-05	0.000333	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.5e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.5e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.5e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.5e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—S100B—epilepsy syndrome	1.46e-05	0.000317	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SOCS3—epilepsy syndrome	1.44e-05	0.000314	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDC42—epilepsy syndrome	1.44e-05	0.000313	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.4e-05	0.000304	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.4e-05	0.000304	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AVP—epilepsy syndrome	1.39e-05	0.000303	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.39e-05	0.000303	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HES1—epilepsy syndrome	1.32e-05	0.000286	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.31e-05	0.000286	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FYN—epilepsy syndrome	1.28e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—H2AFX—epilepsy syndrome	1.28e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MEF2C—epilepsy syndrome	1.27e-05	0.000277	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.24e-05	0.000271	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.24e-05	0.000271	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.24e-05	0.000271	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.24e-05	0.000271	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.24e-05	0.000271	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—YWHAZ—epilepsy syndrome	1.23e-05	0.000268	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGF—epilepsy syndrome	1.22e-05	0.000265	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.22e-05	0.000265	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.21e-05	0.000263	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR5—epilepsy syndrome	1.18e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2A—epilepsy syndrome	1.16e-05	0.000252	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.14e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.14e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.14e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TSC2—epilepsy syndrome	1.1e-05	0.000239	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGT—epilepsy syndrome	1.1e-05	0.000239	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.1e-05	0.000238	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOE—epilepsy syndrome	1.08e-05	0.000234	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.06e-05	0.00023	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.06e-05	0.00023	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—epilepsy syndrome	1.05e-05	0.00023	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.03e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCB—epilepsy syndrome	1.02e-05	0.000221	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6ST—epilepsy syndrome	1.01e-05	0.00022	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	9.95e-06	0.000216	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	9.67e-06	0.000211	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NT5E—epilepsy syndrome	9.43e-06	0.000205	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALAD—epilepsy syndrome	9.43e-06	0.000205	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—POMC—epilepsy syndrome	9.25e-06	0.000201	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL2—epilepsy syndrome	9.05e-06	0.000197	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	8.99e-06	0.000196	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	8.99e-06	0.000196	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	8.8e-06	0.000192	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADSL—epilepsy syndrome	8.62e-06	0.000188	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GLUL—epilepsy syndrome	8.46e-06	0.000184	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.3e-06	0.000181	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF2—epilepsy syndrome	8.18e-06	0.000178	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	7.76e-06	0.000169	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RELA—epilepsy syndrome	7.59e-06	0.000165	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	7.54e-06	0.000164	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MTOR—epilepsy syndrome	7.44e-06	0.000162	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.24e-06	0.000158	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—epilepsy syndrome	6.91e-06	0.00015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—epilepsy syndrome	6.85e-06	0.000149	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6.82e-06	0.000148	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6.82e-06	0.000148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUN—epilepsy syndrome	6.65e-06	0.000145	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—epilepsy syndrome	6.47e-06	0.000141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.35e-06	0.000138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—epilepsy syndrome	6.28e-06	0.000137	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.22e-06	0.000135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SRC—epilepsy syndrome	5.97e-06	0.00013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—epilepsy syndrome	5.81e-06	0.000126	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.56e-06	0.000121	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.41e-06	0.000118	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.38e-06	0.000117	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.34e-06	0.000116	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.87e-06	0.000106	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.86e-06	0.000106	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.62e-06	0.000101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.6e-06	0.0001	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.39e-06	9.56e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.34e-06	9.46e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TH—epilepsy syndrome	4.33e-06	9.42e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.26e-06	9.28e-05	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—epilepsy syndrome	3.71e-06	8.07e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.61e-06	7.86e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.56e-06	7.76e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.47e-06	7.55e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.22e-06	7.02e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.83e-06	6.15e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.77e-06	6.03e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.38e-06	5.18e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.17e-06	4.72e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.9e-06	4.13e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	9.54e-07	2.08e-05	CbGpPWpGaD
